These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 11353744

  • 1. Consumption of watercress fails to alter coumarin metabolism in humans.
    Murphy SE, Johnson LM, Losey LM, Carmella SG, Hecht SS.
    Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
    [Abstract] [Full Text] [Related]

  • 2. Effects of watercress consumption on urinary metabolites of nicotine in smokers.
    Hecht SS, Carmella SG, Murphy SE.
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):907-13. PubMed ID: 10548320
    [Abstract] [Full Text] [Related]

  • 3. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
    Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O.
    Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
    [Abstract] [Full Text] [Related]

  • 4. Determination of coumarin metabolism in Turkish population.
    Cok I, Aygün Kocabaş N, Cholerton S, Karakaya AE, Sardaş S.
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
    Pasanen M, Rannala Z, Tooming A, Sotaniemi EA, Pelkonen O, Rautio A.
    Toxicology; 1997 Dec 05; 123(3):177-84. PubMed ID: 9355936
    [Abstract] [Full Text] [Related]

  • 6. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED, Hankins DC, Taraday JK.
    Drug Metab Dispos; 2000 Jan 05; 28(1):28-33. PubMed ID: 10611136
    [Abstract] [Full Text] [Related]

  • 7. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
    Sotaniemi EA, Rautio A, Bäckstrom M, Arvela P, Pelkonen O.
    Br J Clin Pharmacol; 1995 Jan 05; 39(1):71-6. PubMed ID: 7756103
    [Abstract] [Full Text] [Related]

  • 8. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H, Irshaid Y, Vågbø CB, Brunsvik A, Cholerton S, Zahlsen K, Idle JR.
    Eur J Clin Pharmacol; 1998 Jul 05; 54(5):437-41. PubMed ID: 9754990
    [Abstract] [Full Text] [Related]

  • 9. Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.
    von Weymarn LB, Murphy SE.
    Chem Res Toxicol; 2001 Oct 05; 14(10):1386-92. PubMed ID: 11599930
    [Abstract] [Full Text] [Related]

  • 10. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK, Thummel KE, Kharasch ED.
    Drug Metab Dispos; 1996 Sep 05; 24(9):976-83. PubMed ID: 8886607
    [Abstract] [Full Text] [Related]

  • 11. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED, Hankins DC, Baxter PJ, Thummel KE.
    Clin Pharmacol Ther; 1998 Jul 05; 64(1):39-45. PubMed ID: 9695717
    [Abstract] [Full Text] [Related]

  • 12. N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes.
    von Weymarn LB, Felicia ND, Ding X, Murphy SE.
    Chem Res Toxicol; 1999 Dec 05; 12(12):1254-61. PubMed ID: 10604876
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y, Yang TJ, Krausz KW, Gonzalez FJ, Gelboin HV.
    Pharmacogenetics; 1999 Apr 05; 9(2):229-37. PubMed ID: 10376770
    [Abstract] [Full Text] [Related]

  • 15. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
    Patten CJ, Peterson LA, Murphy SE.
    Drug Metab Dispos; 1998 Feb 05; 26(2):177-80. PubMed ID: 9456305
    [Abstract] [Full Text] [Related]

  • 16. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.
    Zhuo X, Gu J, Zhang QY, Spink DC, Kaminsky LS, Ding X.
    J Pharmacol Exp Ther; 1999 Feb 05; 288(2):463-71. PubMed ID: 9918546
    [Abstract] [Full Text] [Related]

  • 17. Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism.
    Felicia ND, Rekha GK, Murphy SE.
    Arch Biochem Biophys; 2000 Dec 15; 384(2):418-24. PubMed ID: 11368333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini.
    Satarug S, Lang MA, Yongvanit P, Sithithaworn P, Mairiang E, Mairiang P, Pelkonen P, Bartsch H, Haswell-Elkins MR.
    Cancer Epidemiol Biomarkers Prev; 1996 Oct 15; 5(10):795-800. PubMed ID: 8896890
    [Abstract] [Full Text] [Related]

  • 20. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O, Rautio A, Raunio H, Pasanen M.
    Toxicology; 2000 Apr 03; 144(1-3):139-47. PubMed ID: 10781881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.